[Clinical and experimental studies of the combined use of dibasol and furosemide].
A combined use of dibasol and furosemide was demonstrated to be followed by a decrease of furosemide toxic effect on the rat liver, an increase of its diuretic effect in patients and changes of furosemide metabolism kinetics in individuals.
Astashkin
E I
EI
Sarbash
V I
VI
Glezer
M G
MG
Kosheleva
N A
NA
Tishchenkova
I F
IF
D000818:Animals; D001562:Benzimidazoles / Q000627:therapeutic use* / Q000633:toxicity; D003327:Coronary Disease / Q000188:drug therapy; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D004359:Drug Therapy, Combination; D005260:Female; D005665:Furosemide / Q000627:therapeutic use* / Q000633:toxicity; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D066298:In Vitro Techniques; D007668:Kidney / Q000187:drug effects; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D051379:Mice; D008875:Middle Aged; D051381:Rats
D001562:Benzimidazoles; C004453:bendazole; D005665:Furosemide; D003577:Cytochrome P-450 Enzyme System
Kliniko-éksperimental'noe izuchenie sochetannogo ispol'zovaniia dibazola i furosemida.